Clinical Trial Update: Hereditary Spherocytosis and Vascular Function [NA]

View source ↗

Summary

Completed clinical trial evaluating hereditary spherocytosis and vascular function (NCT04451785). Sponsored by Hospices Civils de Lyon.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Spherocytosis

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hereditary Spherocytosis | NA | Status: COMPLETED